LOS ANGELES, Oct. 7, 2019 /PRNewswire/ --On behalf of AARP's 3.3 million California members, we thank Governor Newsom for signing AB 824 into law, which bans "pay-to-delay" agreements between brand-name and generic drug companies, which have kept low-cost generic medications off the market. Now, Californians will have access to more lower-cost options for their prescription medications. We are especially grateful to Attorney General Becerra for sponsoring and Assemblymember Wood for authoring this important legislation that puts people before profits. No one should ever have to choose between paying for food and paying for their medications. AB 824 represents a significant step toward the goal of affordable prescription drugs for all Californians. AARP continues to work at the federal and state level to stop drug companies from price gouging all Americans.
ABOUT AARP: AARP is the nation's largest nonprofit, nonpartisan organization dedicated to empowering Americans 50 and older to choose how they live as they age. With nearly 38 million members and offices in every state, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, AARP works to strengthen communities and advocate for what matters most to families with a focus on health security, financial stability and personal fulfillment. AARP also works for individuals in the marketplace by sparking new solutions and allowing carefully chosen, high-quality products and services to carry the AARP name. As a trusted source for news and information, AARP produces the nation's largest circulation publications, AARP The Magazine and AARP Bulletin. To learn more, visit www.aarp.org or follow @AARP and @AARPadvocates on social media.
View original content to download multimedia:http://www.prnewswire.com/news-releases/statement-of-aarp-california-state-director-nancy-mcpherson-on-governor-newsoms-signing-of-ab-824-300933453.html
SOURCE AARP - California